View in EDS HTML Full Text PDF Full Text

Review projecting shikonin as a therapeutic candidate in female carcinomas: a preclinical perspective.

Saved in:
Bibliographic Details
Title: Review projecting shikonin as a therapeutic candidate in female carcinomas: a preclinical perspective.
Authors: Pandey P; Research and Innovation Cell, Rayat Bahra University, Mohali, Punjab, India., Lakhanpal S; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India., Jamuna KV; Department of Forensic Science, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India., Singh A; School of Applied and Life Sciences, Uttaranchal University, Dehradun, India., Abohassan M; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.; Health and Medical Researches Centre, King Khalid University, Abha, Saudi Arabia., Park MN; Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea., Shin SW; Department of Humanities and Social Medicine, School of Korean Medicine, Pusan National University, Yangsan-si, Republic of Korea., Kang HN; KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea., Zahera M; Department of Biotechnology, Era University, Lucknow, Uttar Pradesh, India., Saeed M; Department of Biology, College of Science, University of Hail, Hail, Saudi Arabia., Khan F; Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India., Kim B; Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Source: Frontiers in pharmacology [Front Pharmacol] 2025 Jul 04; Vol. 16, pp. 1627124. Date of Electronic Publication: 2025 Jul 04 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40689201
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Review projecting shikonin as a therapeutic candidate in female carcinomas: a preclinical perspective.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pandey+P%22">Pandey P</searchLink>; Research and Innovation Cell, Rayat Bahra University, Mohali, Punjab, India.<br /><searchLink fieldCode="AU" term="%22Lakhanpal+S%22">Lakhanpal S</searchLink>; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.<br /><searchLink fieldCode="AU" term="%22Jamuna+KV%22">Jamuna KV</searchLink>; Department of Forensic Science, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.<br /><searchLink fieldCode="AU" term="%22Singh+A%22">Singh A</searchLink>; School of Applied and Life Sciences, Uttaranchal University, Dehradun, India.<br /><searchLink fieldCode="AU" term="%22Abohassan+M%22">Abohassan M</searchLink>; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.; Health and Medical Researches Centre, King Khalid University, Abha, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Park+MN%22">Park MN</searchLink>; Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+SW%22">Shin SW</searchLink>; Department of Humanities and Social Medicine, School of Korean Medicine, Pusan National University, Yangsan-si, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+HN%22">Kang HN</searchLink>; KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Zahera+M%22">Zahera M</searchLink>; Department of Biotechnology, Era University, Lucknow, Uttar Pradesh, India.<br /><searchLink fieldCode="AU" term="%22Saeed+M%22">Saeed M</searchLink>; Department of Biology, College of Science, University of Hail, Hail, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Khan+F%22">Khan F</searchLink>; Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.<br /><searchLink fieldCode="AU" term="%22Kim+B%22">Kim B</searchLink>; Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2025 Jul 04; Vol. 16, pp. 1627124. <i>Date of Electronic Publication: </i>2025 Jul 04 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40689201
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2025.1627124
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1627124
    Titles:
      – TitleFull: Review projecting shikonin as a therapeutic candidate in female carcinomas: a preclinical perspective.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pandey P
      – PersonEntity:
          Name:
            NameFull: Lakhanpal S
      – PersonEntity:
          Name:
            NameFull: Jamuna KV
      – PersonEntity:
          Name:
            NameFull: Singh A
      – PersonEntity:
          Name:
            NameFull: Abohassan M
      – PersonEntity:
          Name:
            NameFull: Park MN
      – PersonEntity:
          Name:
            NameFull: Shin SW
      – PersonEntity:
          Name:
            NameFull: Kang HN
      – PersonEntity:
          Name:
            NameFull: Zahera M
      – PersonEntity:
          Name:
            NameFull: Saeed M
      – PersonEntity:
          Name:
            NameFull: Khan F
      – PersonEntity:
          Name:
            NameFull: Kim B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 07
              Text: 2025 Jul 04
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1